|
|
|
|
|||||
|
|
|
CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.
A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/d69xRqMspwymhwGUDdQoes/JC9qqvWhWggYawxGnDNtmz
About Carlsmed, Inc.
Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
Investor Relations
Caroline Corner, PhD
[email protected]
Media
LeAnn Burton
Senior Director Brand Marketing
[email protected]
| Feb-26 | |
| Feb-26 | |
| Feb-25 | |
| Feb-23 | |
| Feb-19 | |
| Feb-18 | |
| Feb-11 | |
| Feb-10 | |
| Jan-12 | |
| Jan-06 | |
| Dec-16 | |
| Dec-09 | |
| Dec-03 | |
| Nov-19 | |
| Nov-06 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite